These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome]. Arimura K Rinsho Shinkeigaku; 1999 Jan; 39(1):84-5. PubMed ID: 10377815 [TBL] [Abstract][Full Text] [Related]
4. [Vascular endothelial growth factor and Crow-Fukase syndrome]. Arimura K; Osame M; Hashiguchi T Rinsho Shinkeigaku; 2001 Dec; 41(12):1144-6. PubMed ID: 12235821 [TBL] [Abstract][Full Text] [Related]
5. Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case. Sobue G; Doyu M; Watanabe M; Hayashi F; Mitsuma T Acta Neuropathol; 1992; 84(2):171-7. PubMed ID: 1523972 [TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology]. Misawa S Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354 [TBL] [Abstract][Full Text] [Related]
13. The kidney disease of Crow-Fukase (POEMS) syndrome: a clinico-pathological study of four cases. Fukatsu A; Tamai H; Nishikawa K; Matsukawa W; Yoshida F; Matsuo S; Takeda A; Kodera K; Morozumi K; Ito Y Clin Nephrol; 1991 Aug; 36(2):76-82. PubMed ID: 1934663 [TBL] [Abstract][Full Text] [Related]
14. Microenvironment of the peripheral nervous system under normal and pathological conditions. Olsson Y Crit Rev Neurobiol; 1990; 5(3):265-311. PubMed ID: 2168810 [TBL] [Abstract][Full Text] [Related]
15. The blood-nerve barrier: structure and functional significance. Weerasuriya A; Mizisin AP Methods Mol Biol; 2011; 686():149-73. PubMed ID: 21082370 [TBL] [Abstract][Full Text] [Related]